Dacuronium bromide
A non-depolarizing neuromuscular blocking agent
Dacuronium bromide | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Dacuronium bromide is a non-depolarizing neuromuscular blocking agent used in anesthesia to induce muscle relaxation during surgery or mechanical ventilation. It is part of the aminosteroid class of neuromuscular blockers.
Mechanism of Action
Dacuronium bromide works by competitively inhibiting the action of acetylcholine at the neuromuscular junction. It binds to the nicotinic acetylcholine receptor on the motor end plate, preventing acetylcholine from binding and triggering muscle contraction. This results in muscle paralysis, which is reversible with the administration of acetylcholinesterase inhibitors such as neostigmine.
Pharmacokinetics
Dacuronium bromide is administered intravenously. It has a rapid onset of action, typically within 2 to 3 minutes, and a duration of action of approximately 30 to 60 minutes. The drug is metabolized in the liver and excreted primarily in the urine.
Clinical Use
Dacuronium bromide is used in various surgical procedures to facilitate endotracheal intubation and provide muscle relaxation. It is also used in the intensive care setting to facilitate mechanical ventilation in patients who require prolonged respiratory support.
Side Effects
Common side effects of dacuronium bromide include hypotension, tachycardia, and bronchospasm. Rarely, it may cause anaphylaxis or prolonged neuromuscular blockade, especially in patients with hepatic or renal impairment.
Contraindications
Dacuronium bromide is contraindicated in patients with known hypersensitivity to the drug or any of its components. Caution is advised in patients with myasthenia gravis or other neuromuscular disorders.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD